The US Food and Drug Administration has approved a new nasal spray for depression treatment. Known as Spravato and ...
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...
In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.
CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
13h
California gastroenterologist Dr. Saurabh Sethi has called out three popular drinks that increase the risk of Alzheimer’s.
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
A new nasal drug has been approved to treat depression. The drug Spravato is a nasal spray made by Johnson and Johnson.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback